Position in JNJ
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$6,379,980
+$198,582 QoQ
Shares Held
25,121
-0.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.46%
of 13F equity value
Holder Rank
#1,436
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 13%
Shared 0%
None 87%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MARATHON CAPITAL MANAGEMENT holds $31,900,311 across 10 Drug Manufacturers - General names. JNJ ranks #2 (20.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
64,777 | $12,283,014 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
25,121 | $6,379,980 | |
| 3 | NVO |
Novo Nordisk A S
|
78,134 | $3,745,743 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,351 | $3,000,603 | |
| 5 | LLY |
ELI LILLY & Co
|
2,492 | $2,988,979 | |
| 6 | ABBV |
AbbVie Inc.
|
6,807 | $1,712,913 | |
| 7 | AMGN |
Amgen Inc
|
2,533 | $917,249 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,325 | $479,686 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,379,980 | 25,121 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $6,181,398 | 25,288 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,419,192 | 26,186 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $5,328,229 | 28,736 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,461,674 | 29,209 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,879,344 | 29,422 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,326,018 | 29,913 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,813,019 | 29,699 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,336,274 | 29,668 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,544,482 | 28,728 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,476,494 | 28,560 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,420,808 | 28,384 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,954,416 | 35,974 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $5,634,715 | 36,353 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,522,801 | 36,925 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,034,681 | 36,941 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,686,086 | 26,399 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,691,632 | 26,472 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,532,499 | 26,495 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $4,403,136 | 27,264 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,293,783 | 26,064 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,353,138 | 26,487 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $4,023,419 | 25,565 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $3,876,835 | 26,040 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,913,873 | 27,831 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,652,232 | 27,852 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||